Noninvasive Treatment Options for Peyronie's Disease.

作者: Jesse Ory , Landan MacDonald , Gavin Langille

DOI: 10.1016/J.SXMR.2019.12.002

关键词:

摘要: Abstract Introduction Evidence for noninvasive management of Peyronie’s disease contains many options with varying levels evidence each. Many first-line treatments recommended by urologists lack strong their use. Aim We summarize the (oral medications, topical traction, vacuum erection devices, extracorporeal shock wave therapy, intracavernosal injections and electromotive therapy) treatment provide Methods A literature search PubMed, EMBASE, Cochrane Library, ClinicalKey databases was conducted, current up to April 2019. Main Outcome Measure For each modality, we measured level evidence, change in penile curvature, erectile function, percentage patients improved angulation, pain scores. Results There is weak support use oral or medications. Higher exist therapy may be helpful certain patient populations. Conclusion The mechanisms behind are not fully understood. Penile highest quality treatment. Ory J, MacDonald L, Langille G. Noninvasive Treatment Options Disease. Sex Med Rev 2020;8:603–614.

参考文章(82)
Martin Gelbard, Arie Lindner, Milos Chvapil, Joseph Kaufman, Topical beta-aminopropionitrile in the treatment of Peyronie's disease. The Journal of Urology. ,vol. 129, pp. 746- 748 ,(1983) , 10.1016/S0022-5347(17)52339-3
Carrie A. Stewart, Faysal A. Yafi, Margaret Knoedler, Sree H. Mandava, Ian R. McCaslin, Premsant Sangkum, Suresh Sikka, Landon Trost, Wayne J.G. Hellstrom, Intralesional Injection of Interferon-α2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location. The Journal of Urology. ,vol. 194, pp. 1704- 1707 ,(2015) , 10.1016/J.JURO.2015.06.096
James P. Tursi, David J. Ralph, Laurence A. Levine, Beatrice Cuzin, Stephen Mark, Martin K. Gelbard, Nigel A. Jones, Genzhou Liu, Gregory J. Kaufman, Clinical Safety and Effectiveness of Collagenase Clostridium Histolyticum Injection in Patients With Peyronie's Disease: A Phase 3 Open-Label Study The Journal of Sexual Medicine. ,vol. 12, pp. 248- 258 ,(2015) , 10.1111/JSM.12731
Roberto Frairia, Laura Berta, Biological effects of extracorporeal shock waves on fibroblasts. A review. Muscles, ligaments and tendons journal. ,vol. 1, pp. 138- 147 ,(2011)
F. A. Yafi, M. R. Pinsky, P. Sangkum, W. J.G. Hellstrom, Therapeutic advances in the treatment of Peyronie's disease. Journal of Andrology. ,vol. 3, pp. 650- 660 ,(2015) , 10.1111/ANDR.12058
G. Paulis, R. D’Ascenzo, P. Nupieri, G. De Giorgio, G. Orsolini, T. Brancato, R. Alvaro, Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: a study of 151 cases. International Journal of Andrology. ,vol. 35, pp. 521- 527 ,(2012) , 10.1111/J.1365-2605.2011.01219.X
Mohammad Reza Safarinejad, Majid Ali Asgari, Seyyed Yousof Hosseini, Farid Dadkhah, A double‐blind placebo‐controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie’s disease BJUI. ,vol. 106, pp. 240- 248 ,(2009) , 10.1111/J.1464-410X.2009.09041.X
Boback M. Berookhim, Judy Choi, Byron Alex, John P. Mulhall, Deformity stabilization and improvement in men with untreated Peyronie's disease. BJUI. ,vol. 113, pp. 133- 136 ,(2014) , 10.1111/BJU.12346
Martin K. Gelbard, Frederick Dorey, Kathleen James, The Natural History of Peyronie’s Disease Journal of Urology. ,vol. 144, pp. 1376- 1379 ,(1990) , 10.1016/S0022-5347(17)39746-X
Gerald H. Jordan, Culley C. Carson, Larry I. Lipshultz, Minimally invasive treatment of Peyronie's disease: evidence-based progress BJU International. ,vol. 114, pp. 16- 24 ,(2014) , 10.1111/BJU.12634